Rating Change
Barclays analysts initiated coverage on Medtronic plc (NYSE:MDT) with a rating of Equal-Weight on October 07, 2026.
new coverageNYSE:MDT
Barclays Initiates Coverage on Medtronic plc (MDT) with Equal-Weight
Barclays analysts initiated coverage on Medtronic plc (NYSE:MDT) with a rating of Equal-Weight on October 07, 2026.
At publication ·
What changed
Medtronic plc (NYSE:MDT) · new coverage
- Firm
- Barclays
- Rating
- Equal-Weight
- Price at event
- $85.51
- Market capitalization
- $127.9B
At a glance
Key takeaways
- Barclays initiated coverage of Medtronic (MDT) on October 7, 2026 with an Equal-Weight rating, indicating neutral expectations for the stock.
- MDT trades at $85.51 with a market cap of $127.9B and has declined 10.9% over the past 52 weeks.
Market Context
Medtronic plc operates in the Healthcare sector. The stock currently trades at $85.51 with a market capitalization of $127.9B. The stock has declined 10.9% over the past 52 weeks.
Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Medtronic plc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Medtronic plc
Among the 10 most recent ratings: 6 Buy, 4 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 07, 2026 | Barclays | Equal-Weight | N/A |
| Sep 30, 2026 | TD Cowen | Buy | N/A |
| Sep 03, 2026 | UBS | Buy | N/A |
| Sep 02, 2026 | Truist Securities | Hold | N/A |
| Sep 02, 2026 | Wells Fargo | Overweight | N/A |
Related Tools: Analyst Ratings Dashboard | View MDT Stock Page
Frequently Asked Questions
What does the Equal-Weight rating mean for MDT?
A rating of Equal-Weight from Barclays reflects the analyst's outlook on Medtronic plc (NYSE:MDT). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the MDT forecast page.
